Skip to content

Public FDA record

Z-1527-2020: ev3 Pipeline Flex Embolization Device. For neurological endovascular use.

Recall record Z-1527-2020 for Micro Therapeutics Inc, Dba Ev3 Neurovascular. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1527-2020
Company in FDA record
Micro Therapeutics Inc, Dba Ev3 Neurovascular
FDA classification date
Mar 9, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Embolization device delivery system may fracture at the distal section during device implantation. A weakened bond may result in unintended separation, where the distal portion of the device delivery system remains in the patient. If a Pipeline Flex embolization device has already been implanted successfully, there is no increased risk to patients due to this issue.

Source facts

Action
On 02/14/20, Medtronic mailed Urgent Medical Device Recall notices to Healthcare Professionals and Risk Managers. They were advised of the following: 1) Do not use any affected product. Remove and quarantine all unused affected products in your inventory. 2) Return the affected products. Medtronic representatives can assist with facilitating the return of affected product and with identifying suitable replacement product. 3) Complete and return the Customer Confirmation Form. In addition, customers were asked to share the communication within their organization, with other organizations where affected devices were transferred, and any other associated organizations that may be impacted. On 09/04/2020, a Safety and Labeling Notification was sent to customers informing them that that Instructions for Use will be supplemented to update the Precaution and Warning statements and the Device Complications section. Medtronic recommends that physician users be attentive to the updated information in the Instructions for Use and include this information in discussions with patients. Further, please share this communication within your organization, with other organizations where these devices have been transferred, and any other associated organizations that may be impacted by this action.
Initiated
2020-02-14
Root cause
Process change control
Terminated
2024-06-12
Distribution
Worldwide distribution. US nationwide, Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Italy, Japan, Jordan, Kazakhstan, Korea, Lebanon, Mexico, Netherlands, Norway, Paraguay, Poland, Qatar, Russian Federation, Saudi Arabia, Serbia, Slovakia, Spain, Sweden, Switzerland, Taiwan, Turkey, United Arab Emirates, United Kingdom, Uruguay, and Viet Nam
Recall number
Z-1527-2020
Recall status
Terminated
CDRH record ID
180023
FDA classified
2020-03-09
Recall event number
85069

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗